Two pharmacy benefit manager studies find increasing fees and declining opinions as House considers action
Two recent studies about pharmacy benefit managers spotlight declining opinions of the industry and growing fees that have shifted profits away from rebates.
Both studies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
